BroveX PSB DM LIQUID — Class II drug recall D-527-2013
Terminated recall by TG United, Inc., reported 2013-06-12, distributed in FL, LA, MS, SC, TX. CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
| Recall number | D-527-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | TG United, Inc., Brooksville, FL, United States |
| Recall initiated | 2013-01-30 |
| Classified | 2013-06-04 |
| Reported by FDA | 2013-06-12 |
| Terminated | 2016-09-30 |
| Distributed | FL, LA, MS, SC, TX |
| Reason classes | cgmp |
| NDC | 58605-0151-01, 58605-0151-02 |
| Lot numbers | 01/13, 10/13, 11AQ004, 11AQ005, 11AQ006, 11AQ007, 11BQ012, 11LQ003, 11LQ004, 11LQ005, 11LQ006, 12/12 |
| Expiration dates | 2013-10 |
Product
BroveX PSB DM LIQUID, Antihistamine, Decongestant, a) 16 fl oz. bottle, OTC, NDC 58605-151-01 b) 20 ml NDC 58605-151-02, Manufactured for: Pernix Therapeutics, Gonzales, LA 70737
Reason for recall
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-527-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.